Register for June 26, 2018 Webinar


Tuesday, June 26, 2018, 2:00 PM - 3:00 PM EDT 

Program Description 

Managed Care Considerations for Advances in Anticoagulation Reversal Therapy 

The advent of the direct acting oral anticoagulants (DOACs) has provided a convenient alternative to traditional anticoagulation with warfarin or low-molecular weight heparins. The DOACs have proven benefits for stroke prevention, and for both treatment and prevention of venous thromboembolism (VTE). The DOACs all carry the risk of major bleeding. Delineating the differences in the bleeding rates between products and the resulting economic impact is essential in determining the most appropriate anticoagulant for an individual patient.

This program will compare the prevalence of bleeding between the individual agents, address the economic impact of major bleeds, and discuss current techniques for managing excessive anticoagulation. Additionally, the mechanisms of action and available efficacy data for currently approved and investigational anticoagulant reversal agents will be presented.

Learning Objectives 

At the completion of this activity, participants should be able to:

  1. Detail the impact of major bleeds per anticoagulant agent in terms of prevalence, patient outcomes, and economic impact.
  2. Discuss current strategies for the treatment of direct oral anticoagulants (DOACs)-associated bleeding.
  3. Identify at least one currently marketed and one investigational anticoagulant reversal product, and outline where each medication may fit into current anticoagulation bleeding treatment guidelines.

Target Audience 

This knowledge-based activity has been designed to meet the educational needs of pharmacists in managed care settings.

Faculty Presenters  

Angela A. Allerman, PharmD, BCPS
Clinical Pharmacist
Deputy Chief, P&T Section
Formulary Management Branch
Defense Health Agency
San Antonio, Texas


Christine L. Cooper, PharmD
Education Program Manager
Academy of Managed Care Pharmacy
Alexandria, Virginia

2:00 pm to 2:05 pm        Welcome and Introductions
Christine L. Cooper, PharmD 
2:05 pm to 2:50 pm   Managed Care Considerations for Advances in Anticoagulation Reversal Therapy
Angela A. Allerman, PharmD, BCPS 
2:50 pm to 3:00 pm   Audience Q&A
Christine L. Cooper, PharmD

ACPE UAN #: 0233-0000-18-047-L04-P

Credit: 1.0 contact hours (0.1 CEU)

Activity Type: Knowledge-based

Activity Fee: There is no fee to participate in this activity.

 ACPE LogoThe Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

As an ACPE-accredited provider, AMCP strictly adheres to the ACPE Standards for Commercial Support and other relevant guidelines and standards to ensure the independence of CPE activities. It is AMCP’s intent that all CPE activities be independent, objective, balanced, evidence-based and free of any commercial bias.

 AMCP Logo 

Earning CPE Credit 

To earn continuing pharmacy education (CPE) credit for this program, you must attend the entire session and participate in the pre- and post-test questions. Once completed, go to to claim CPE credit. In the enrollment code redemption area, enter the enrollment code provided during the session. Complete the program evaluation and enter your NABP ID and date of birth (MMDD). Please allow 72 hours for processing and posting in your NABP account. All CPE credit for this webinar activity must be completed no later than 5:00 PM EDT on Monday, July 30, 2018. No exceptions can be made after this date.

Statement of Commercial Support 

This educational activity is supported by an unrestricted educational grant from Portola Pharmaceuticals, Inc.


This continuing education activity is provided at no cost to participants, but space is limited to the first 500 participants that join the webinar.

System Technical Requirements/Viewing Requirements  

For all activities, you should have a basic comfort level using a computer and navigating websites.

The live webinar is delivered through GoToWebinar. To view minimum technical and system requirements for the webinar, please use your web browser to check your system requirements by clicking here. Space is limited to the first 500 participants that join the webinar.

The handout will be delivered via Acrobat PDF.

CPE credit will be claimed through AMCP Learn. View the minimum technical and system requirements for continuing education online learning activities by clicking here.